SCHEMBL7418892

SCHEMBL7418892

COc1ccc(Cl)cc1S(=O)(=O)N[C@@H](Cc1ccc(OCCCONC(=N)N)cc1)C(=O)OC(=O)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
ITGB3 P05106 4/20 0.41
ITGAV P06756 2/20 0.41
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ITGA2B P08514 2/20 0.36
PPARG P37231 1/20 0.35
ALPL P05186 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
PPARA Q07869 1/20 0.34
WDR5 P61964 1/20 0.34
F10 P00742 1/20 0.34
AVPR1A P37288 1/20 0.34
ITGB1 P05556 1/20 0.33
ITGA5 P08648 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415180 0.93 CYP3A4 (0.45) CYP3A4CYP2C19ITGB3ITGAVITGA2B
SCHEMBL7419767 0.92 CYP3A4 (0.44) CYP3A4CYP2C19ITGB3ITGAVLMNA
SCHEMBL7414783 0.91 CYP3A4 (0.43) CYP3A4CYP2C19ITGB3ITGAVITGA2B
SCHEMBL7408015 0.91 PSMB5 (0.38) ITGB3ITGAVHTTITGA2BPPARG
Trifluoroacetic Acid SCHEMBL7418891 0.90 ITGB3 (0.49) CYP3A4CYP2C19ITGB3ITGAVLMNA
SCHEMBL7416348 0.89 ITGB3 (0.36) ITGB3ITGAVITGA2BPPARAITGB1
SCHEMBL7416867 0.88 NPSR1 (0.40) CYP3A4CYP2C19ITGB3ITGAVNPSR1
SCHEMBL7411729 0.88 ITGB3 (0.53) CYP3A4CYP2C19ITGB3ITGAVLMNA
SCHEMBL7412118 0.86 ACLY (0.38) ITGB3ITGA2BPPARAITGB1ITGA5
SCHEMBL7414232 0.86 ITGB3 (0.37) CYP3A4CYP2C19ITGB3HTTITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed